跳至主要内容
临床试验/NCT01271088
NCT01271088已完成2 期

Phase 3 Study of Protective Effect of N-acetylcysteine Against From Ototoxicity

TC Erciyes University1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2010年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
60
试验地点
1
主要终点
Threshold hearing levels

研究概览

简要总结

Peritonitis is currently one of the leading complications of continuous ambulatory peritoneal dialysis (CAPD). Aminoglycosides and vancomycin are used in the treatment of CAPD peritonitis despite their potential risk for ototoxicity. NAC is a molecule used in the treatment and prophylaxis of many diseases related to oxidative stress. The aim of this study was to examine whether ototoxicity due to antibiotics used in the treatment of CAPD peritonitis can be prevented by N-acetylcysteine

详细描述

NAC, a thiol-containing antioxidant because of this,we want to investigate antioxidant status.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • End-stage renal disease
  • Undergoing continuous ambulatory peritoneal dialysis as a renal replacement therapy
  • Developing the first continuous ambulatory peritoneal dialysis related peritonitis episode

排除标准

  • Being treated with aminoglycoside antibiotics and vancomycine within the previous 3 months
  • Detection of mechanical occlusion of external ear
  • Having signs of disturbed integrity of tympanic membrane on otoscopy or tympanometry
  • History of a continuous ambulatory peritoneal dialysis related peritonitis

研究组 & 干预措施

Control

No Intervention

Vancomycine and/or amikacin alone

干预措施: N-acetylcysteine (Drug)

N-acetylcysteine

Experimental

N-acetylcysteine: Experimental N-acetylcysteine 600 mg twice daily + vancomycine and/or amikacin

干预措施: N-acetylcysteine (Drug)

结局指标

主要结局

Threshold hearing levels

时间窗: 4 weeks

Ototoxicity was defined as an increase in the auditory threshold by at least 20 dB at any one test frequency, or at least 10 dB at any two adjacent frequencies, or loss of response at three consecutive frequencies between the baseline and follow-up studies in the worse ear.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ismail Kocyigit

TC Erciyes University Department of Nephrology

TC Erciyes University

研究点 (1)

Loading locations...

相似试验